The estimated Net Worth of Robert J Mac Donald is at least $14.5 Thousand dollars as of 6 August 2019. Mr. Donald owns over 5,000 units of Obalon Therapeutics Inc stock worth over $14,529 and over the last 5 years he sold OBLN stock worth over $0. In addition, he makes $0 as Chief Retail Officer at Obalon Therapeutics Inc.
Robert has made over 1 trades of the Obalon Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of OBLN stock worth $20,000 on 6 August 2019.
The largest trade he's ever made was buying 5,000 units of Obalon Therapeutics Inc stock on 6 August 2019 worth over $20,000. On average, Robert trades about 1,000 units every 0 days since 2019. As of 6 August 2019 he still owns at least 5,245 units of Obalon Therapeutics Inc stock.
You can see the complete history of Mr. Donald stock trades at the bottom of the page.
Bob MacDonald is Chief Retail Officer of the company. With over 25 years of corporate development and management experience, Mr. MacDonald has been helping retailers and consumer services companies develop and execute strategies to acquire new customers, expand into new markets, and drive profitable growth. In his most recent role, Mr. MacDonald was VP of Growth for Sono Bello, where he expanded the network of cosmetic surgery clinics from 16 in 2016 to over 40 in 2019. He was responsible for real estate, construction, staffing, and operational ramp-up for all new clinics, opening up 15 new markets in the Midwest, mid-Atlantic, and Southwest regions. Mr. MacDonald was also responsible for the launch and testing of new products and services within Sono Bello, including the Obalon Balloon System. Prior to Sono Bello, he held both corporate strategy and management leadership roles at Staples (7 years) and McDonald's (10 years), where he led the operational turn-around of over 800 McDonald's restaurants. Mr. MacDonald also has over 10 years of experience in management consulting with Ernst & Young and Oliver Wyman, and is currently working as an independent consultant, where his clients have included Wal-Mart and Comcast. Mr. MacDonald holds a BA degree in Economics from the University of Notre Dame, and earned his MBA from Harvard Business School.
Robert's mailing address filed with the SEC is C/O OBALON THERAPEUTICS, INC., 5421 AVENDA ENCINAS, SUITE F, CARLSBAD, CA, 92008.
Over the last 8 years, insiders at Obalon Therapeutics Inc have traded over $0 worth of Obalon Therapeutics Inc stock and bought 3,260,355 units worth $6,939,913 . The most active insiders traders include Parters Vii L Pblair James ..., Partners X Lp Inter West Ma..., and David Moatazedi. On average, Obalon Therapeutics Inc executives and independent directors trade stock every 54 days with the average trade being worth of $432,771. The most recent stock trade was executed by William J. Plovanic on 12 November 2019, trading 65,000 units of OBLN stock currently worth $107,900.
Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.
Obalon Therapeutics Inc executives and other stock owners filed with the SEC include: